cyc 202 has been researched along with ldc4297 in 3 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (ldc4297) | Trials (ldc4297) | Recent Studies (post-2010) (ldc4297) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 8 | 0 | 8 |
| Protein | Taxonomy | cyc 202 (IC50) | ldc4297 (IC50) |
|---|---|---|---|
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.053 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.0064 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 0.0034 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 1.711 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, S; Galons, H; Huang, Y; Ingarra, AM; Li, T; Lu, K; Oumata, N; Teng, Y; Yu, P; Zhang, Q; Zhao, L | 1 |
| Bharate, SB; Raghuvanshi, R | 1 |
| Albert, T; Antrecht, C; Baumgart, K; Eickhoff, J; Kelso, TW; Klebl, B; Lemcke, S; Meisterernst, M | 1 |
1 review(s) available for cyc 202 and ldc4297
| Article | Year |
|---|---|
Recent advances in the development of cyclin-dependent kinase 7 inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Drug Development; Humans; Protein Kinase Inhibitors; Pyrimidines; Triazines | 2019 |
2 other study(ies) available for cyc 202 and ldc4297
| Article | Year |
|---|---|
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases | 2022 |
Cyclin-dependent kinase 7 controls mRNA synthesis by affecting stability of preinitiation complexes, leading to altered gene expression, cell cycle progression, and survival of tumor cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HEK293 Cells; HeLa Cells; Humans; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; RNA Polymerase II; RNA, Messenger; Roscovitine; Triazines | 2014 |